{
  "Figure": "1-s2.0-S1556086415333955-main_page2_51.jpg",
  "Figure_title": "subsequently developed bowel obstruction, gastrointestinal hemorrhage, and aspiration pneumonia leading to death. The other patient, a 63-year-old woman, experienced neutropenic sepsis and pneumonia after nine courses of pemetrexed and motexaﬁn and ultimately died of cardiogenic shock. Unfor- tunately, the 6-month progression free survival, overall sur- vival, response rate, clinical beneﬁt ratio were also similar to that which would be expected from pemetrexed as a single agent (Table 3). "
}